drugset / Trial / NCT06532253
Long-term Safety Trial with NVDX3
Phase 1/2
Recruiting
15 enrolled
Novadip Biosciences
Data Investigation Company Europe (DICE) · collabPrimeVigilance · collab
NaSingle-groupOpen-labelTreatment
Summary
An study evaluating the long-term safety of all patients previously treated with NVDX3.
Timeline
- Start
- 2024-08-22
- Primary completion
- 2036-03
- Completion
- 2036-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NVDX3 | Other / unclassified | — | Other |